Objective: To describe the validation process of the analytic method for the valsartan
quantification in human plasma by HPL-CUV and its application in pharmacokinetic, bioavailability and bioequivalence studies of products that contain the active principle valsartan
Exforge utilizes two complementary mechanisms of action through the calcium channel blocker (CCB) amlodipine and the angiotensin receptor blocker (ARB) valsartan
Exforge is a single table combination of the antihypertensive medicines amlodipine (CCB) and Valsartan
Two long-term trials have compared an ARB to other types of drug therapy: losartan vs atenolol in the Losartan Intervention for Endpoint Reduction (LIFE) trial, (6) and valsartan
vs amlodipine in the Valsartan
Antihypertensive Long-term Use Evaluation (VALUE) trial.
The landmark Valiant clinical trial into the drug, also known as valsartan
, involving 14,703 patients worldwide found that is as effective at improving survival after a heart attack as the conventional Ace inhibitor treatments for those patients also taking other 'background' treatments such as aspirin, beta-blockers and statins.
The landmark trial involved 15,000 patients in 24 countries and the results, published today, show that a drug called valsartan
provides an effective alternative to conventional medication.
ACE inhibitors/ARBS--captopril, lisinopril, quinapril, ramipril/losartan, valsartan
He reported on 17,532 individuals who underwent an oral glucose tolerance test as part of the screening process for participation in the Nateglinide and Valsartan
in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Limited Tenders are invited for Supply of TAb Sacubitril 24 mg with Valsartan
26 mg like Tab Vymada 50 mg
Objective: To analyze the effects of glutamine and valsartan
on the brain natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) of patients with chronic heart failure (CHF).
This study aimed to investigate the inhibitory effects of AT [sub]1 R antagonist valsartan
on platelet aggregation and the occurrence of cardio-cerebral thrombotic events in elderly patients with hypertension.
LCZ-696 consists of a 1:1 mixture of the ARB valsartan
and the novel neprilysin inhibitor AHU-377.